You are viewing the site in preview mode

Skip to main content
Fig. 1 | Clinical Proteomics

Fig. 1

From: Quantitative site-specific N-glycosylation analysis reveals IgG glyco-signatures for pancreatic cancer diagnosis

Fig. 1

Differentially expressed site-specific N-glycopeptides between HC and PDAC groups. (A), differentially expressed N-glycopeptides subclasses between HC and PDAC groups; (B) and (C), differentially expressed site-specific N-glycopeptides between HC and PDAC groups; HC, healthy control; PDAC, pancreatic ductal adenocarcinoma; IgG, immunoglobulin G; *, p<0.05; **, p<0.01

Back to article page

Clinical Proteomics

ISSN: 1559-0275